Solvay
2019 Annual Integrated Report

Accounting policy

A discontinued operation is a component of the Group which the Group has disposed of or which is classified as held for sale (see note F30 Assets held for sale), and which:

  • represents a separate major line of business or geographical area of operations;
  • is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or
  • is a subsidiary acquired exclusively with a view to resale.

A component of the Group consists of operations and cash flows, which can be clearly distinguished operationally and for financial reporting purposes, from the rest of the Group.

In the consolidated statement of comprehensive income, the consolidated statement of cash flows, and disclosures, discontinued operations are re-presented for prior periods presented.

2019
In € million

Polyamides

Other

Total

Net sales

1,463

 

1,463

EBIT

332

14

347

Financial result

(3)

1

(2)

Tax

(109)

 

(109)

Profit from discontinued operations

221

15

236

attributable to Solvay share

221

15

236

Polyamides EBIT includes M&A costs for € (16) million.

The € 15 million in the column “Other” mainly results from post-closing warranties related to the disposal of the Pharma business and an adjustment for the Indupa purchase price.

2018
In € million

Polyamides

Other

Total

Net sales

1,563

 

1,563

EBIT

288

(4)

284

Financial result

(3)

 

(3)

Tax

(80)

 

(80)

Profit (loss) from discontinued operations

205

(5)

201

attributable to Solvay share

205

(5)

201

Polyamides EBIT includes M&A costs for € (18) million.

The € (5) million in the column “Other” referred to post-closing adjustments related to the disposal of Acetow.